72 related articles for article (PubMed ID: 11029756)
1. Overexpressed poly(ADP-ribose) polymerase delays the release of rat cells from p53-mediated G(1) checkpoint.
Wesierska-Gadek J; Schmid G
J Cell Biochem; 2000 Sep; 80(1):85-103. PubMed ID: 11029756
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.
Wesierska-Gadek J; Schmid G
Cell Mol Biol Lett; 2001; 6(2):117-40. PubMed ID: 11544635
[TBL] [Abstract][Full Text] [Related]
3. p53-mediated regulation of cell cycle progression: pronounced impact of cellular microenvironment.
Schmid G; Kramer MP; Wesierska-Gadek J
J Cell Physiol; 2009 May; 219(2):459-69. PubMed ID: 19170070
[TBL] [Abstract][Full Text] [Related]
4. Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout cells to antitumor triazoloacridone C-1305 is associated with permanent G2 cell cycle arrest.
Wesierska-Gadek J; Schloffer D; Gueorguieva M; Uhl M; Skladanowski A
Cancer Res; 2004 Jul; 64(13):4487-97. PubMed ID: 15231658
[TBL] [Abstract][Full Text] [Related]
5. Advantage of a baculovirus expression system for protein-protein interaction studies. Involvement of posttranslational phosphorylation in the interaction between wt p53 protein and poly(ADP-ribose) polymerase-1.
Schmid G; Wojciechowski J; Wesierska-Gadek J
Acta Biochim Pol; 2005; 52(3):713-9. PubMed ID: 16082409
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation regulates the interaction and complex formation between wt p53 protein and PARP-1.
Wesierska-Gadek J; Wojciechowski J; Schmid G
J Cell Biochem; 2003 Aug; 89(6):1260-84. PubMed ID: 12898523
[TBL] [Abstract][Full Text] [Related]
7. Reduced stability of regularly spliced but not alternatively spliced p53 protein in PARP-deficient mouse fibroblasts.
Wesierska-Gadek J; Wang ZQ; Schmid G
Cancer Res; 1999 Jan; 59(1):28-34. PubMed ID: 9892179
[TBL] [Abstract][Full Text] [Related]
8. PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Samara R; Espinoza LA; Hassa PO; Hottiger MO; Smulson ME
Oncogene; 2003 Nov; 22(52):8460-71. PubMed ID: 14627987
[TBL] [Abstract][Full Text] [Related]
9. Effect of simulated microgravity conditions on poly(ADP-ribose) polymerase activity in primary cultures of adult rat hepatocytes.
Cesarone CF; Pippia P; Demori I; Scarabelli L; Fugassa E
J Gravit Physiol; 2001 Jul; 8(1):P127-8. PubMed ID: 12650200
[TBL] [Abstract][Full Text] [Related]
10. Etoposide (VP-16) sensitizes p53-deficient human non-small cell lung cancer cells to caspase-7-mediated apoptosis.
Chiu CC; Lin CH; Fang K
Apoptosis; 2005 May; 10(3):643-50. PubMed ID: 15909125
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) polymerase localizes to the centrosomes and chromosomes.
Kanai M; Uchida M; Hanai S; Uematsu N; Uchida K; Miwa M
Biochem Biophys Res Commun; 2000 Nov; 278(2):385-9. PubMed ID: 11097846
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation.
Kanai M; Hanashiro K; Kim SH; Hanai S; Boulares AH; Miwa M; Fukasawa K
Nat Cell Biol; 2007 Oct; 9(10):1175-83. PubMed ID: 17891139
[TBL] [Abstract][Full Text] [Related]
13. ADP-ribosylation of wild-type p53 in vitro: binding of p53 protein to specific p53 consensus sequence prevents its modification.
Wesierska-Gadek J; Schmid G; Cerni C
Biochem Biophys Res Commun; 1996 Jul; 224(1):96-102. PubMed ID: 8694840
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of poly(ADP-ribose) polymerase activity accelerates T-cell lymphomagenesis in p53 deficient mice.
Beneke R; Möröy T
Oncogene; 2001 Dec; 20(56):8136-41. PubMed ID: 11781827
[TBL] [Abstract][Full Text] [Related]
15. Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome.
Brustmann H
Int J Gynecol Pathol; 2007 Apr; 26(2):147-53. PubMed ID: 17413981
[TBL] [Abstract][Full Text] [Related]
16. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
Ling YH; Liebes L; Jiang JD; Holland JF; Elliott PJ; Adams J; Muggia FM; Perez-Soler R
Clin Cancer Res; 2003 Mar; 9(3):1145-54. PubMed ID: 12631620
[TBL] [Abstract][Full Text] [Related]
18. Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line.
Wu GS; Ding Z
Oncogene; 2002 Jan; 21(1):1-8. PubMed ID: 11791171
[TBL] [Abstract][Full Text] [Related]
19. Action of a novel anticancer agent, CHS 828, on mouse fibroblasts: increased sensitivity of cells lacking poly (ADP-Ribose) polymerase-1.
Lövborg H; Wojciechowski J; Larsson R; Wesierska-Gadek J
Cancer Res; 2002 Aug; 62(15):4206-11. PubMed ID: 12154020
[TBL] [Abstract][Full Text] [Related]
20. Defective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase.
Agarwal ML; Agarwal A; Taylor WR; Wang ZQ; Wagner EF; Stark GR
Oncogene; 1997 Aug; 15(9):1035-41. PubMed ID: 9285557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
